30.6.2025 08:00:00 CEST | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state
Aqua Bio Technology ASA has appointed Kristian Flaten as Chief Executive
Officer, effective from 1 August 2025.
During an interim period, Kristian will also hold the position as Chief
Financial Officer.
Kristian Flaten brings over 25 years of financial and business leadership, with
proven track record in management, finance, corporate governance and business
development from listed growth companies and international organisations.
Kristian has a background as CFO with IDEX Biometrics ASA and Quantafuel ASA,
with additional experience from BW Offshore, Eksportkreditt (Eksfin) and
Handelsbanken.
Kristian holds a Master of Science from NHH (Norwegian School of Economics),
with majors in Finance and Strategy.
The board of Aqua Bio Technology has previously announced that the company will
enter a phase with new priorities and cost adjustments. The board will conclude
on these topics during the second half of 2025.
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
CONTACTS
* Roger Sedal, Chair of the Board of Directors, Aqua Bio Technology ASA,
+4740002002, roger@sedal.no
* Terje Blytt, JetCarrier AS, +4769184030
ABOUT AQUA BIO TECHNOLOGY ASA
Aqua Bio Technology ASA (ABTEC) is a distribution group i skincare and non-food.
The group has distribution towards B2C, B2B, B2B2, and freight, customs, and
logistics services. The group also develops sustainable biotechnology for use in
skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo. market
of the Oslo Stock Exchange.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18584231/6260/Download%20announce
ment%20as%20PDF.pdf